Life Sciences

Alnair Therapeutics

The University of Chicago

Alnair Therapeutics is creating a novel lactate-inducible drug release platform to deliver drug specifically to tumor sites for cancer treatment.

This company will be presenting on Day 2 of DeepTechU 2022. View schedule >>